The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
TAZNI: A phase I/II combination trial of tazemetostat with nivolumab and ipilimumab for children with INI1-negative or SMARCA4-deficient tumors.
 
Joanna S. Yi
No Relationships to Disclose
 
Jeffrey Czaplinski
Employment - Atrius Health (I)
 
Ketki Bhushan
No Relationships to Disclose
 
Suzanne J. Forrest
No Relationships to Disclose
 
Neerav Shukla
Consulting or Advisory Role - Illumina
 
Stephen C. Mack
No Relationships to Disclose
 
Andrew Lee Hong
No Relationships to Disclose
 
Alex Kentsis
Stock and Other Ownership Interests - Rgenta Therapeutics
Consulting or Advisory Role - Blueprint Medicines; Day One Therapeutics; Novartis; Rgenta; Syndax
Patents, Royalties, Other Intellectual Property - EMD Millipore
 
Mackenzie Stinehart
No Relationships to Disclose
 
Suzanne Ezrre
No Relationships to Disclose
 
Marylynne Strachan
No Relationships to Disclose
 
Steven G. DuBois
Consulting or Advisory Role - Amgen; Bayer; InhibRx; Jazz Pharmaceuticals
Research Funding - Bayer (Inst); BMS (Inst); Curis (Inst); Eisai (Inst); Lilly (Inst); Loxo (Inst); Merck (Inst); Pfizer (Inst); Roche/Genentech (Inst); Salarius Pharmaceuticals (Inst); Turning Point Therapeutics (Inst)
Travel, Accommodations, Expenses - Roche/Genentech; Salarius Pharmaceuticals
(OPTIONAL) Uncompensated Relationships - Ymabs Therapeutics Inc
 
Wendy B London
Consulting or Advisory Role - Healthcasts; Jubilant Radiopharma; Y-mAbs Therapeutics
Research Funding - Aileron Therapeutics; Bluebird Bio; Bristol-Myers Squibb; Novartis
 
Susan N. Chi
Consulting or Advisory Role - Blueprint Medicines; Bristol-Myers Squibb/Roche; Epizyme
Travel, Accommodations, Expenses - Epizyme